Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients

Radiotherapy and Oncology

Volumn 118, Issue 1, 2016, Pages 176-180

  Sage, Eva K ^a   Schmid, Thomas E ^a,b,c   Sedelmayr, Michael ^a   Gehrmann, Mathias ^a   Geinitz, Hans ^d   Duma, Marciana N ^a,b   Combs, Stephanie E ^a,b,c   Multhoff, Gabriele ^a,b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b IFT INSTITUT FÜR THERAPIEFORSCHUNG   (Germany)

^c Deutsches Konsortium für Translationale Krebsforschung DKTK Partner Site München   (Germany)

^d JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

Breast cancer; Chemotherapy; Lymphocyte subpopulations; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER ADJUVANT THERAPY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; ADJUVANT CHEMOTHERAPY; BREAST NEOPLASMS; CHEMORADIOTHERAPY; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 84959291913     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.11.016     Document Type: Article

References (26)

1. S. Corradini, M. Niyazi, O.M. Niemoeller, M. Li, F. Roeder, R. Eckel, and et al. Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study Radiother Oncol 114 2015 28 34
2. J. Stjernsward, M. Jondal, F. Vanky, H. Wigzell, and R. Sealy Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma Lancet 1 7765 1972 1352 1356
3. S. Demaria, and S.C. Formenti Sensors of ionizing radiation effects on the immunological microenvironment of cancer Int J Radiat Biol 83 2007 819 825
4. O. Cho, Y.T. Oh, M. Chun, O.K. Noh, J.S. Hoe, and H. Kim Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer Head Neck 2015 10.1002/hed.24158 (Epub ahead)
5. Y.B. Cihan, A. Arslan, M.F. Cetindag, and H. Mutlu Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer Asian Pac J Cancer Prev 15 2014 4225 4231
6. P.J. Schuler, V. Borger, E. Bolke, D. Habermehl, C. Matuschek, C.A. Wild, and et al. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy Eur J Med Res 16 2011 57 62
7. K.L. Ling, S.E. Pratap, G.J. Bates, B. Singh, N.J. Mortensen, B.D. George, and et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients Cancer Immun 7 2007 7
8. M. Haas, A. Dimmler, W. Hohenberger, G.G. Grabenbauer, G. Niedobitek, and L.V. Distel Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia BMC Gastroenterol 9 2009 65
9. P. Salama, M. Phillips, F. Grieu, M. Morris, N. Zeps, D. Joseph, and et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer J Clin Oncol 27 2009 186 192
10. S. Rangwala, and K. Tsai Roles of the immune system in skin cancer Br J Dermatol 165 2011 953 965
11. B. Charbonneau, E.L. Goode, K.R. Kalli, K.L. Knutson, and M.S. DeRycke The immune system in the pathogenesis of ovarian cancer Crit Rev Immunol 33 2013 137 164
12. L.A. Emens, and G. Middleton The interplay of immunotherapy and chemotherapy: harnessing potential synergies Cancer Immunol Res 3 2015 436 443
13. S. Demaria, E.B. Golden, and S.C. Formenti Role of local radiation therapy in cancer immunotherapy JAMA Oncol 2015
14. K.D. MacClatchey Clinical laboratory medicine 2002 Lippincott Wiliams & Wilkins Philadelphia
15. U.S. Gaipl, G. Multhoff, H. Scheithauer, K. Lauber, S. Hehlgans, B. Frey, and et al. Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy Immunotherapy 6 2014 597 610
16. P. Balaram, M.R. Pillai, T.K. Padmanabhan, T. Abraham, N.K. Hareendran, and M.K. Nair Immune function in malignant cervical neoplasia: a multiparameter analysis Gynecol Oncol 31 1988 409 423
17. H. Chapel, N. Snowden, S.A. Misbah, and M. Haeney Essentials of clinical immunology 2014 Wiley-Blackwell Chichester, West Sussex, UK
18. N. Wijayahadi, M.R. Haron, J. Stanslas, and Z. Yusuf Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens J Chemother 19 2007 716 723
19. C. Belka, H. Ottinger, E. Kreuzfelder, M. Weinmann, M. Lindemann, A. Lepple-Wienhues, and et al. Impact of localized radiotherapy on blood immune cells counts and function in humans Radiother Oncol 50 1999 199 204
20. H. Geinitz, F.B. Zimmermann, P. Stoll, R. Thamm, W. Kaffenberger, K. Ansorg, and et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer Int J Radiat Oncol Biol Phys 51 2001 691 698
21. U.K. Liyanage, T.T. Moore, H.G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, and et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2002 2756 2761
22. M. Muthana, G. Multhoff, and A.G. Pockley Tumour infiltrating host cells and their significance for hyperthermia Int J Hyperthermia 26 2010 247 255
23. A.D. Santin, P.L. Hermonat, A. Ravaggi, S. Bellone, J. Roman, S. Pecorelli, and et al. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix Int J Radiat Oncol Biol Phys 48 2000 997 1006
24. Y. Qu, S. Jin, A. Zhang, B. Zhang, X. Shi, J. Wang, and et al. Gamma-ray resistance of regulatory CD4+ CD25+ Foxp3+ T cells in mice Radiat Res 173 2010 148 157
25. F. Mozaffari, C. Lindemalm, A. Choudhury, H. Granstam-Bjorneklett, M. Lekander, B. Nilsson, and et al. Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study Cancer Immunol Immunother 58 2009 111 120
26. G. Multhoff, T. Meier, C. Botzler, M. Wiesnet, A. Allenbacher, W. Wilmanns, and et al. Differential effects of ifosfamide on the capacity of cytotoxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels Blood 85 1995 2124 2131